Rachel V. Amaral
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rachel V. Amaral has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Angela de Castro Resende
Department of Pharmacology and Psychobiology, Roberto Alcantara Gomes Biology Institute (IBRAG), Rio de Janeiro State University (UERJ), Rio de Janeiro 20551-030, RJ, Brazil
1 shared publication - Carlos Eduardo da Silva Monteiro
Program of Research in Drug Development, Institute of Biomedical Science, Federal University of Rio de Janeiro, UFRJ, Brazil. Av. Carlos Chagas Filho, 373 - Centro de Ciências da Saúde - bloco J, sala 14. Cidade Universitária - Ilha do Fundão, Rio de Janeiro, 21941-902, Brazil.
1 shared publication - Gisele Zapata-Sudo
Programa de Pós-Graduação em Cardiologia, Instituto do Coração Edson Saad, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-913, RJ, Brazil
1 shared publication - Miguel L. Neto
Department of Pharmacology and Psychobiology, IBRAG, State University of Rio de Janeiro, UERJ, Av. 28 de setembro, 87 fundos 5° andar sala 7, Vila Isabel, Rio de Janeiro, 20551-030, Brazil.
1 shared publication - Pergentino José Cunha Souza
Departament of Pharmacy, Federal University of Pará, Belém, PA, Brazil
1 shared publication - Roberto Soares de Moura
Rio de Janeiro State University, 28130, Pharmacology, Rio de Janeiro, Brazil ;
1 shared publication
Latest Publications
- Open Access
- 2 July 2015
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 15 (1) , 208
Antinociceptive effects of hydroalcoholic extract from Euterpe oleracea Mart. (Açaí) in a rodent model of acute and neuropathic pain
Plants rich in flavonoids, such as açaí (Euterpe oleraceae Mart.), can induce antinociception in experimental animals. Here, we tested an extract obtained from the stones of açaí fruits (açaí stone extract, ASE), a native plant from the Amazon region of Brazil, in models of acute/inflammatory and chronic pain. Antinociceptive effects of ASE were evaluated in the hot plate, formalin, acetic acid writhing, carrageenan, and neuropathic pain models, as well as in thermal hyperalgesia and mechanical allodynia models induced by spinal nerve ligation. Antinociceptive activities were modulated by the administration of cholinergic, adrenergic, opioid, and L-arginine-NO antagonists. Oral administration of ASE (30, 100, or 300 mg.kg−1) dose-dependently reduced nociceptive responses to acute/inflammatory pain in mice, including thermal hyperalgesia, acetic acid-induced writhing, and carrageenan-induced thermal hyperalgesia. Moreover, ASE reduced the neurogenic and inflammatory phases after intraplantar injection of formalin in mice. The antinociceptive effect of ASE (100 mg · kg−1) in a hot plate protocol, was inhibited by pre-treatment with naloxone (1 mg · kg−1), atropine (2 mg · kg−1), yohimbine (5 mg · kg−1), or L-NAME (30 mg · kg−1). Furthermore, ASE prevented chronic pain in a rat spinal nerve ligation model, including thermal hyperalgesia and mechanical allodynia. ASE showed significant antinociceptive effect via a multifactorial mechanism of action, indicating that the extract may be useful in the development of new analgesic drugs.
- 2 July 2015
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 15 (1) , 208
Open AccessAntinociceptive effects of hydroalcoholic extract from Euterpe oleracea Mart. (Açaí) in a rodent model of acute and neuropathic pain
Plants rich in flavonoids, such as açaí (Euterpe oleraceae Mart.), can induce antinociception in experimental animals. Here, we tested an extract obtained from the stones of açaí fruits (açaí stone extract, ASE), a native plant from the Amazon region of Brazil, in models of acute/inflammatory and chronic pain. Antinociceptive effects of ASE were evaluated in the hot plate, formalin, acetic acid writhing, carrageenan, and neuropathic pain models, as well as in thermal hyperalgesia and mechanical allodynia models induced by spinal nerve ligation. Antinociceptive activities were modulated by the administration of cholinergic, adrenergic, opioid, and L-arginine-NO antagonists. Oral administration of ASE (30, 100, or 300 mg.kg−1) dose-dependently reduced nociceptive responses to acute/inflammatory pain in mice, including thermal hyperalgesia, acetic acid-induced writhing, and carrageenan-induced thermal hyperalgesia. Moreover, ASE reduced the neurogenic and inflammatory phases after intraplantar injection of formalin in mice. The antinociceptive effect of ASE (100 mg · kg−1) in a hot plate protocol, was inhibited by pre-treatment with naloxone (1 mg · kg−1), atropine (2 mg · kg−1), yohimbine (5 mg · kg−1), or L-NAME (30 mg · kg−1). Furthermore, ASE prevented chronic pain in a rat spinal nerve ligation model, including thermal hyperalgesia and mechanical allodynia. ASE showed significant antinociceptive effect via a multifactorial mechanism of action, indicating that the extract may be useful in the development of new analgesic drugs.